GlassScriptPhysician profile
Jerone Douglas Duke
NPI 1134395072
$6,175.01
in general payments reported to CMS, 2019-2025
28 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $776 · 2021: $408 · 2022: $592 · 2023: $935 · 2024: $1,485 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,537.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,759.80 | 2019-2025 | Puraply, Via Matrix, Cygnus Dual |
| Mimedx Group, INC. | $1,196.28 | 2024-2025 | |
| Smith+Nephew, INC. | $765.18 | 2019-2025 | Collagenase Santyl, Regranex |
| Medtronic, INC. | $620.06 | 2021-2025 | Venaseal |
| Paratek Pharmaceuticals, INC. | $339.74 | 2022-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $204.90 | 2019-2021 | |
| Solventum Corporation | $161.03 | 2024-2025 | Activ.A.C., 3m Cavilon |
| Cumberland Pharmaceuticals, INC. | $123.92 | 2022-2023 | Vibativ |
| Kci USA, INC. | $117.73 | 2019-2021 | |
| Integra Lifesciences Corporation | $108.20 | 2019-2020 | |
| Abbvie INC. | $101.06 | 2021-2024 | |
| Angiodynamics, INC. | $99.63 | 2024 | Auryon Laser System 100-120 Vac |
| Kerecis Limited | $86.03 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Allergan, INC. | $79.92 | 2019-2020 | |
| Mozarc Medical US LLC | $63.24 | 2025 | Palindrome |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $50.87 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $46.93 | 2025 | Zerbaxa |
| Aroa Biosurgery Incorporated | $45.78 | 2023-2024 | |
| Biowound Solutions, INC. | $35.36 | 2025 | Bio-Connekt |
| Averitas Pharma INC. | $29.10 | 2024 | Qutenza |
| Convatec INC. | $23.98 | 2024 | |
| Ossur Americas, INC. | $21.04 | 2025 | |
| Urgo Medical North America, LLC | $18.55 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Tactile Systems Technology INC | $17.89 | 2023 | Flexitouch Plus, Entre Plus |
| Misonix INC | $15.63 | 2020 | |
| 3m Company | $15.37 | 2019 | |
| Bioventus LLC | $14.46 | 2022 | |
| Next Science LLC | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerone Duke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.